Cole SI, Chisholm D, Hughes J, Adams C, Callaghan D, Whiting A, Ambler C (2023) LXD191 is a novel, triple-action photosensitizer-histone deacetylase targeting inhibitor drug-drug conjugate: the efficient and selective killing of human oral cancer cells and animal tissue upon irradiation
But the headline numbers undersell whats really happening here
But one researcher, John Cawley, a professor of economics and public policy at Cornell University, and his colleagues found that while obesity basically doubles a persons annual health care costs, the savings associated with public insurance plans covering GLP-1s for just obesity treatment are dependent on the patients starting body mass index, or BMI
Injectable or IV glutathione formulations require a prescription from a licensed physician and must be prepared by a compounding pharmacy operating under state and federal oversight